Last reviewed · How we verify
Placebo matching Seroquel IR
This is a placebo formulation matching the appearance and characteristics of Seroquel IR (quetiapine immediate-release) used as a control in clinical trials.
This is a placebo formulation matching the appearance and characteristics of Seroquel IR (quetiapine immediate-release) used as a control in clinical trials. Used for Control arm in clinical trials for conditions treated with Seroquel IR (schizophrenia, bipolar disorder, major depressive disorder).
At a glance
| Generic name | Placebo matching Seroquel IR |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo matching formulations are inactive preparations designed to be indistinguishable from the active drug in appearance, taste, and administration to maintain blinding in randomized controlled trials. In this case, it mimics Seroquel IR tablets but contains no active quetiapine ingredient, allowing researchers to isolate the true pharmacological effects of quetiapine from placebo response effects.
Approved indications
- Control arm in clinical trials for conditions treated with Seroquel IR (schizophrenia, bipolar disorder, major depressive disorder)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo matching Seroquel IR CI brief — competitive landscape report
- Placebo matching Seroquel IR updates RSS · CI watch RSS
- AstraZeneca portfolio CI